Foghorn Therapeutics Inc. Interest Expense
Foghorn Therapeutics Inc. (FHTX) reported Interest Expense of $0 for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2022-11-08
- Foghorn Therapeutics Inc. interest expense for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Foghorn Therapeutics Inc. interest expense for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Foghorn Therapeutics Inc. interest expense for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Foghorn Therapeutics Inc. interest expense for the quarter ending 2021-12-31 was $426.00K, a 32.71% increase year-over-year.
- Foghorn Therapeutics Inc. interest expense for fiscal 2021 was $1.91M, a 94.69% increase from fiscal 2020.
- Foghorn Therapeutics Inc. interest expense for fiscal 2020 was $979.00K, a 81.30% increase from fiscal 2019.
- Foghorn Therapeutics Inc. interest expense for fiscal 2019 was $540.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $426.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $426.00K derived: sum of 3 quarters · filed 2022-08-09 | $925.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | $426.00K derived: sum of 2 quarters · filed 2022-08-09 | $925.00K derived: sum of 3 quarters · filed 2022-11-08 | $1.42M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-12-31 | $426.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-08-09 | $925.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.42M derived: sum of 3 quarters · filed 2022-11-08 | $1.91M 10-K/A · filed 2022-08-09 |
| 2021-09-30 | $499.00K 10-Q · filed 2022-11-08 | $994.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.48M 10-Q · filed 2022-11-08 | $1.80M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $495.00K 10-Q · filed 2022-08-09 | $981.00K 10-Q · filed 2022-08-09 | $1.30M derived: sum of 3 quarters · filed 2022-08-09 | $1.50M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $486.00K 10-Q · filed 2022-05-09 | $807.00K derived: sum of 2 quarters · filed 2022-08-09 | $1.01M derived: sum of 3 quarters · filed 2022-08-09 | $1.21M derived: sum of 4 quarters · filed 2022-08-09 |
| 2020-12-31 | $321.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-08-09 | $523.00K derived: sum of 2 quarters · filed 2022-08-09 | $721.00K derived: sum of 3 quarters · filed 2022-08-09 | $979.00K 10-K/A · filed 2022-08-09 |
| 2020-09-30 | $202.00K 10-Q · filed 2021-11-09 | $400.00K derived: sum of 2 quarters · filed 2021-11-09 | $658.00K 10-Q · filed 2021-11-09 | $836.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $198.00K 10-Q · filed 2021-08-10 | $456.00K 10-Q · filed 2021-08-10 | $634.00K derived: sum of 3 quarters · filed 2021-08-10 | $747.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $258.00K 10-Q · filed 2021-05-11 | $436.00K derived: sum of 2 quarters · filed 2021-05-11 | $549.00K derived: sum of 3 quarters · filed 2021-05-11 | |
| 2019-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $291.00K derived: sum of 2 quarters · filed 2021-03-18 | $540.00K 10-K · filed 2021-03-18 | |
| 2019-09-30 | $113.00K 10-Q · filed 2020-12-04 | $362.00K 10-Q · filed 2020-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |